Cas:844891-10-7 tert-Butyl 4-(4-bromobenzyl)piperazine-1-carboxylate manufacturer & supplier

We serve Chemical Name:tert-Butyl 4-(4-bromobenzyl)piperazine-1-carboxylate CAS:844891-10-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

tert-Butyl 4-(4-bromobenzyl)piperazine-1-carboxylate

Chemical Name:tert-Butyl 4-(4-bromobenzyl)piperazine-1-carboxylate
CAS.NO:844891-10-7
Synonyms:tert-butyl 4-[(4-bromophenyl)methyl]piperazine-1-carboxylate
Molecular Formula:C16H23BrN2O2
Molecular Weight:355.27000
HS Code:2933599090

Physical and Chemical Properties:
Melting point:69-72ºC
Boiling point:409ºC at 760 mmHg
Density:1.314g/cm3
Index of Refraction:1.558
PSA:32.78000
Exact Mass:354.09400
LogP:3.37760

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like tert-butyl 4-[(4-bromophenyl)methyl]piperazine-1-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,tert-butyl 4-[(4-bromophenyl)methyl]piperazine-1-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,tert-butyl 4-[(4-bromophenyl)methyl]piperazine-1-carboxylate Use and application,tert-butyl 4-[(4-bromophenyl)methyl]piperazine-1-carboxylate technical grade,usp/ep/jp grade.


Related News: CDMOs closely work with companies who want to pursue upcoming innovations in medicines, help cope with shortcomings of internal lab-to-manufacturing scale-up. ethyl (5-((2-(methylcarbamoyl)pyridin-4-yl)oxy)indoline-1-carbonyl)glycinate manufacturers This further investment in enhanced facilities and continuous staff development provides the increased range of testing services required by the international biopharmaceutical industry. bryostatin 4 26-acetate suppliers GSK picked McNamara after six months of “extensive search and selection process,” GSK said in its announcement Thursday. It ran the quest with help from two headhunters and evaluated “several external and internal candidates,” it said. 5-methylbenzo[4,5]imidazo[1,2-c]quinazolin-6(5H)-one vendor & factory But when it came to deciding on whether Americans with compromised immune systems should get an extra dose of any COVID-19 vaccine, the CDC said it would need to wait for the FDA to give its regulatory thumbs up first. That could come either through amending its emergency use nods or awarding full approvals.,This further investment in enhanced facilities and continuous staff development provides the increased range of testing services required by the international biopharmaceutical industry.